{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:49:16Z","timestamp":1791229756157,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"\n Background:<\/jats:title>\n Immunocompromised patients exposed to varicella may experience significant morbidity and a 7% mortality rate. Management and outcome of an outbreak of varicella infection among hospitalized pediatric hemato-oncology patients using the guidelines of the American Academy of Pediatrics Committee on Infectious Diseases are presented.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n This retrospective study describes an outbreak of varicella infection between February 2011 and June 2011. Data were retrieved from the patients\u2019 files. Positive polymerase chain reaction results for varicella zoster virus from vesicular skin lesions were used for the diagnosis of varicella infection.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Twelve pediatric hemato-oncology patients experienced 13 episodes of varicella infection, 11 underwent 1 episode each and 1 patient had 2 episodes. All exposed patients without immunity received varicella zoster immune globulins or intravenous immunoglobulin and were isolated as recommended by the guidelines. Infected patients received intravenous acyclovir. One patient with acute lymphoblastic leukemia at induction chemotherapy died. All the other patients survived.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Our experience in the management of hospitalized immunocompromised patients exposed to varicella was that a positive IgG serology did not confer protection after exposure to varicella infection and thus can not serve as a marker for immunity. Unlike the isolation period sufficient for immunocompetent patients, crusted lesions can be contagious and thus require extended isolation for immunocompromised patients. Patients receiving rituximab are at greater risk of having persistent or recurrent disease. Studies with a larger sample size should be performed to better assess the management of immunocompromized patients exposed to varicella.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/inf.0000000000001920","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T14:25:25Z","timestamp":1516976725000},"page":"649-653","source":"Crossref","is-referenced-by-count":15,"title":["Lessons From an Outbreak of Varicella Infection in Pediatric Hemato-oncology Patients"],"prefix":"10.1097","volume":"37","author":[{"given":"Michal","family":"Manistarski","sequence":"first","affiliation":[{"name":"Pediatric Hemato-Oncology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Levin","sequence":"additional","affiliation":[{"name":"Pediatric Hemato-Oncology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Dvir","sequence":"additional","affiliation":[{"name":"Pediatric Hemato-Oncology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivan","family":"Berger-Achituv","sequence":"additional","affiliation":[{"name":"Pediatric Hemato-Oncology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Rosenfeld Keidar","sequence":"additional","affiliation":[{"name":"Pediatric Hemato-Oncology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Grisaru-Soen","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Carmeli","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tel Aviv Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Elhasid","sequence":"additional","affiliation":[{"name":"Pediatric Hemato-Oncology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/14760584.5.2.295","article-title":"Successes and remaining challenges after 10 years of varicella vaccination in the USA.","volume":"5","author":"Davis","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.vaccine.2013.08.022","article-title":"The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates.","volume":"31","author":"Waye","year":"2013","journal-title":"Vaccine"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2431-11-31","article-title":"Varicella-zoster virus infections in immunocompromised patients: a single centre 6-years analysis.","volume":"11","author":"Wiegering","year":"2011","journal-title":"BMC Pediatr"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1542\/peds.56.3.388","article-title":"Varicella in children with cancer: seventy-seven cases.","volume":"56","author":"Feldman","year":"1975","journal-title":"Pediatrics"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.80.4.465","article-title":"Varicella in children with cancer: impact of antiviral therapy and prophylaxis.","volume":"80","author":"Feldman","year":"1987","journal-title":"Pediatrics"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/archdischild-2012-301684","article-title":"Chickenpox in the immunocompromised child.","volume":"97","author":"Roderick","year":"2012","journal-title":"Arch Dis Child"},{"key":"R9-20230912","first-page":"574","article-title":"Updated recommendations for use of VariZIG\u2014United States, 2013.","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1542\/peds.92.2.219","article-title":"Postexposure prophylaxis of varicella in family contact by oral acyclovir.","volume":"92","author":"Asano","year":"1993","journal-title":"Pediatrics"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1542\/peds.97.1.150","article-title":"Postexposure prophylaxis of varicella in children with leukemia by oral acyclovir.","volume":"97","author":"Ishida","year":"1996","journal-title":"Pediatrics"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/adc.2010.209650","article-title":"PEPtalk: postexposure prophylaxis against varicella in children with cancer.","volume":"96","author":"Bate","year":"2011","journal-title":"Arch Dis Child"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/archdischild-2011-301496","article-title":"Postexposure chickenpox prophylaxis in children with leukaemia: a reply to the recent PEPtalk study and report of a service evaluation in a tertiary paediatric haematology centre in the UK.","volume":"97","author":"Samuelson","year":"2012","journal-title":"Arch Dis Child"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/tropej\/fmv008","article-title":"Successful prevention of varicella outbreak in an overcrowded paediatric oncology ward using oral acyclovir prophylaxis.","volume":"61","author":"Kumar","year":"2015","journal-title":"J Trop Pediatr"},{"key":"R15-20230912","first-page":"289","article-title":"Varicella outbreak in a pediatric oncology ward: the Manado experience.","volume":"11","author":"Gunawan","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jiac.2014.08.006","article-title":"A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapy.","volume":"20","author":"Okamotoa","year":"2014","journal-title":"J Infect Chemother"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<166::AID-MPO7>3.0.CO;2-9","article-title":"Outbreak of varicella in a pediatric oncology unit.","volume":"31","author":"Kavaliotis","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1542\/peds.2005-0219","article-title":"Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.","volume":"116","author":"Hill","year":"2005","journal-title":"Pediatrics"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/pbc.21521","article-title":"Chickenpox in varicella IgG positive patients: experience of a regional paediatric oncology centre.","volume":"51","author":"Manley","year":"2008","journal-title":"Pediatr Blood Cancer"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201807000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:10:40Z","timestamp":1694556640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201807000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001920","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}